Prevention trials aim to halt Alzheimer's before symptoms arise
In the United States and elsewhere two large prevention studies enroll healthy adults aged 55 to 75 to test early interventions that could block initial brain changes linked to Alzheimer's. The studies require APOE4 gene testing via GeneMatch, with participants learning their risk status and consenting to potential study contact, even if they do not carry the gene.